The Veterinary Medicines Department performs further monitoring in the area of veterinary medicines, processes notifications of adverse reactions and comments on safety-relevant topics such as illegal imports and delimitation questions. and health, the dean of the College of Veterinary Medicine, and the director of the Veterinary Diagnostic. The Department regularly coordinates regulatory issues and similar concerning the supply of veterinary medicines in roundtable meetings with the Swiss veterinary pharmaceuticals industry, representatives of veterinarians and the Swiss authorities, such as the Federal Food Safety and Veterinary Office (FSVO).Įxchanging views with national and international authorities on veterinary medicine-specific issues is important, so use is made of this dialogue whenever required. Persistent, progressive weight loss may result in hepatic lipidosis monitoring of body weight is recommended. Veterinary Drug Licence Application (PDF) Schedule A. Atopica is a systemic immunosuppressant that may increase susceptibility to infection, development of neoplasia, and decrease response to vaccination.

It deals with the quality, safety and efficacy of veterinary medicines in the context of new applications, extensions and variations.Īuthorisation documentation for veterinary medicines is assessed by internal and external experts as well as the VMEC. veterinary prescription drugs in compliance with the Compendium of Medicating Ingredients Brochures.

The Veterinary Medicines Department is responsible for authorisation of veterinary medicines.

Compendium of veterinary products pdf